Page 48 - Trident Royalties News Today : Breaking News, Live Updates & Top Stories | Vimarsana

If three months in a row represents a trend, then the trend for mining royalty and streaming businesses is definitely positive.

Power Metal Resources in demand after finding anomalies at Botswana project A look at Friday's major share movers on the London Stock Exchange Power Metal Resources PLC (LON:POW) added 4% to 2.45p before close after finding extensive anomalies at the South Ghanzi Project in Botswana. These findings align closely with previous fieldwork conducted and the established regional exploration model for the discovery of major copper/silver deposits within the Kalahari Copper Belt. “The exploration story at South Ghanzi continues to progress at pace and we eagerly await the next phase of results and...

Trident Royalties highlights progress made on several projects in its portfolio "It is very encouraging to be able to report some significant progress at a number of our royalty companies,” said Trident chief executive Adam Davidson Trident Royalties PLC (LON:TRR) said significant progress had been made by operators of several projects over which it holds royalties. It highlighted developments at Thacker Pass, operated by Lithium Americas Corp, where results of a feasibility study targeting an initial 30,000-35,000 tonnes per annum lithium carbonate equivalent of capacity are expected by ...

Proactive news headlines: Eden Research, Primary Health Properties, Silence Therapeutics, IronRidge Resources... A glance at some of the day's highlights from the Proactive Investors newswire Eden Research PLC (LON:EDEN) said it has signed what it called a ‘milestone agreement’ with Corteva Agrisciences for its seed treatment application. Primary Health Properties PLC (LON:PHP) said its rental collection has remained robust so far in 2021 as the healthcare facilities firm updated investors of its performance for the first quarter, while rental income from its existing portfolio continued ...

FTSE 100 closes on the front foot, with AstraZeneca the top riser Footsie finished Friday ahead by around eight points, or 0.12%, at 6,969, FTSE 100 closes around eight points higher AstraZeneca top blue-chip riser 5.05pm: FTSE closes ahead FTSE 100 closed on the front foot at the end of the trading week, with drugs giant and much-in-the-news COVID-19 vaccine producer AstraZeneca (LON:AZN) the top dog. Footsie finished ahead by around eight points, or 0.12%, at 6,969, with the psychologically significant 7,000 level now coming back into view. Over the week as a whole , the FTSE 100 added ar...